Israel’s largest pharmacy chain Super-Pharm (Israel) is in talks to acquire Teva Pharmaceutical Industries’ plant in the coastal city of Ashdod, a source familiar with the matter said on Sunday, confirming media reports. Super-Pharm would pay 60-80 million shekels ($17-23 million) and is prepared to commit to continue employing the factory’s 70 workers, said the source, who asked not to be named. Super-Pharm is interested in the pharmaceutical preparation activities that have an estimated 100 million shekels in annual sales, the Globes financial news site ...
Israel's Super-Pharm in talks to buy Teva plant
Super-Pharm, which already operates laboratories providing custom-made treatments, did not confirm the talks but said it would be interested in a deal